Rilmenidine therapy potential in pharmaceutical correction of endothelial dysfunction among women with arterial hypertension, Type 2 diabetes mellitus, and visceral obesity

Rilmenidine therapy potential in pharmaceutical correction of endothelial dysfunction among women with arterial hypertension, Type 2 diabetes mellitus, and visceral obesity

Aim. To assess the effectiveness of a selective I1 imidazoline receptor agonist, rilmenidine, in women with Stage I arterial hypertension (AH), Type 2 diabetes mellitus (DM-2), and visceral obesity (VO), taking into account antihypertensive effects and dynamics of endothelial dysfunction (ED) bioche...

Full description

Bibliographic Details
Main Authors: E. V. Eliseeva, O. V. Gaydarova, O. V. Borushnova, L. A. Shapkina, A. M. Morozova
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 1970-01-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
сахарный диабет 2 типа
артериальная гипертензия
висцеральное ожирение
эндотелиальная дисфункция
рилменидин
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1565

Similar Items

Similar Items